HomeCOYA • NASDAQ
add
Coya Therapeutics Inc
Previous close
$8.43
Day range
$8.40 - $8.75
Year range
$3.21 - $10.69
Market cap
125.58M USD
Avg Volume
109.90K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2023info | Y/Y change |
|---|---|---|
Revenue | 6.00M | — |
Operating expense | -1.51M | 46.14% |
Net income | 1.27M | 140.74% |
Net profit margin | 21.09 | — |
Earnings per share | — | — |
EBITDA | 2.02M | 225.43% |
Effective tax rate | 36.38% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2023info | Y/Y change |
|---|---|---|
Cash and short-term investments | 32.63M | 449.86% |
Total assets | 41.26M | 391.48% |
Total liabilities | 5.63M | -66.49% |
Total equity | 35.64M | — |
Shares outstanding | 14.54M | — |
Price to book | 3.41 | — |
Return on assets | 18.89% | — |
Return on capital | 21.96% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2023info | Y/Y change |
|---|---|---|
Net income | 1.27M | 140.74% |
Cash from operations | -2.24M | -0.81% |
Cash from investing | -193.19K | 50.47% |
Cash from financing | 24.17M | 23,329.10% |
Net change in cash | 21.74M | 900.12% |
Free cash flow | -3.08M | -142.72% |
About
Founded
2020
Headquarters
Website
Employees
8
